TY - JOUR
T1 - Linear ubiquitination in immune and neurodegenerative diseases, and beyond
AU - Tokunaga, Fuminori
AU - Ikeda, Fumiyo
N1 - Funding Information:
This work is supported by a Grant for Research Program on Hepatitis from the Japan Agency for Medical Research and Development (19fk0210050h0001 to F.T.), the MEXT/JSPS KAKENHI grants (Nos. JP16H06276 (AdAMS) and JP21H02688 to F.T., and JP21H00288 and JP21H04777 to F.I.), the Takeda Science Foundation (F.T. and F.I.), and the Kobayashi Foundation (F.T.).
Publisher Copyright:
© 2022 The Author(s)
PY - 2022/4
Y1 - 2022/4
N2 - Ubiquitin regulates numerous aspects of biology via a complex ubiquitin code. The linear ubiquitin chain is an atypical code that forms a unique structure, with the C-terminal tail of the distal ubiquitin linked to the N-terminal Met1 of the proximal ubiquitin. Thus far, LUBAC is the only known ubiquitin ligase complex that specifically generates linear ubiquitin chains. LUBAC-induced linear ubiquitin chains regulate inflammatory responses, cell death and immunity. Genetically modified mouse models and cellular assays have revealed that LUBAC is also involved in embryonic development in mice. LUBAC dysfunction is associated with autoimmune diseases, myopathy, and neurodegenerative diseases in humans, but the underlying mechanisms are poorly understood. In this review, we focus on the roles of linear ubiquitin chains and LUBAC in immune and neurodegenerative diseases. We further discuss LUBAC inhibitors and their potential as therapeutics for these diseases.
AB - Ubiquitin regulates numerous aspects of biology via a complex ubiquitin code. The linear ubiquitin chain is an atypical code that forms a unique structure, with the C-terminal tail of the distal ubiquitin linked to the N-terminal Met1 of the proximal ubiquitin. Thus far, LUBAC is the only known ubiquitin ligase complex that specifically generates linear ubiquitin chains. LUBAC-induced linear ubiquitin chains regulate inflammatory responses, cell death and immunity. Genetically modified mouse models and cellular assays have revealed that LUBAC is also involved in embryonic development in mice. LUBAC dysfunction is associated with autoimmune diseases, myopathy, and neurodegenerative diseases in humans, but the underlying mechanisms are poorly understood. In this review, we focus on the roles of linear ubiquitin chains and LUBAC in immune and neurodegenerative diseases. We further discuss LUBAC inhibitors and their potential as therapeutics for these diseases.
UR - http://www.scopus.com/inward/record.url?scp=85129490616&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85129490616&partnerID=8YFLogxK
U2 - 10.1042/BST20211078
DO - 10.1042/BST20211078
M3 - Review article
C2 - 35343567
AN - SCOPUS:85129490616
SN - 0300-5127
VL - 50
SP - 799
EP - 811
JO - Biochemical Society Transactions
JF - Biochemical Society Transactions
IS - 2
ER -